You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GBM, Newly Diagnosed

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Trial in Boston (ITI-1001)

Not yet recruiting
  • Glioblastoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 13, 2023

Newly Diagnosed Glioblastoma Trial ([177Lu]Lu-NeoB, [68Ga]Ga-NeoB, Temozolomide)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • (no location specified)
Feb 13, 2023

Glioblastoma Trial run by the NCI (drug, biological, other)

Completed
  • Glioblastoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 23, 2022

Anaplastic Oligoastrocytoma, Glioblastoma Trial in Guangzhou (Temozolomide)

Recruiting
  • Anaplastic Oligoastrocytoma
  • Glioblastoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 27, 2022

Newly Diagnosed MGMT Unmethylated Glioblastoma Trial in Durham (D2C7-IT, 2141-V11)

Not yet recruiting
  • Newly Diagnosed MGMT Unmethylated Glioblastoma
  • Durham, North Carolina
    Duke University Medical Center
Feb 7, 2023

6 Months Adjuvant Temozolomide vs No Adjuvant TMZ in Newly

Withdrawn
  • MGMT-Methylated Glioblastoma
  • Delay of TMZ
  • Standard of Care (SOC) Adjuvant TMZ (no intervention
  • (no location specified)
Aug 5, 2022

Glioblastoma Multiforme Trial in United States (Nativis Voyager)

Completed
  • Glioblastoma Multiforme
  • Nativis Voyager
  • Tucson, Arizona
  • +6 more
Jan 31, 2023

Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • TVI-Brain-1
  • +3 more
  • (no location specified)
Jan 13, 2023

MGMT-unmethylated Glioblastoma (GBM), GBM Trial in New York (Nivolumab, Ipilimumab, Radiation Therapy (RT))

Completed
Has Results
  • MGMT-unmethylated Glioblastoma (GBM)
  • GBM
  • New York, New York
    New York University School of Medicine
Jun 30, 2022

Glioblastoma Trial (Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide))

Not yet recruiting
  • Glioblastoma
  • Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)
  • (no location specified)
Apr 20, 2022

Glioblastoma, Glioma, Malignant Trial in Durham (MT-201-GBM monocyte vaccine)

Not yet recruiting
  • Glioblastoma
  • Glioma, Malignant
  • MT-201-GBM monocyte vaccine
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University M
May 25, 2022

Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine

Recruiting
  • Glioblastoma, IDH-wildtype
  • +4 more
  • Eflornithine (Dose Level 1)
  • +3 more
  • Cleveland, Ohio
    The Cleveland Clinic
May 19, 2023

Adult Glioblastoma Trial in Gainesville (Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane

Recruiting
  • Adult Glioblastoma
  • Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP liposome vaccine administered intravenously (RNA loaded lipid particles, RNA-LPs)
  • Gainesville, Florida
    UF Health
Aug 30, 2022

Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)

Not yet recruiting
  • Glioma, Malignant
  • Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
  • Hiltonol
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University
Jan 19, 2023

Primary Glioblastoma Trial (AV-GBM-1, Autologous monocytes)

Not yet recruiting
  • Primary Glioblastoma
  • AV-GBM-1
  • Autologous monocytes
  • (no location specified)
Dec 14, 2021

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)

Active, not recruiting
  • Glioblastoma
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 16, 2022

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Guangzhou (VAL-083 (Dianhydrogalactitol))

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083 (Dianhydrogalactitol)
  • Guangzhou, China
    Sun Yat-Sen University Cancer Center
Mar 23, 2022

Glioblastoma Multiforme (GBM) Trial in Taoyuan (ADI-PEG20, Temozolomide)

Recruiting
  • Glioblastoma Multiforme (GBM)
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital, Linkou Branch
Sep 29, 2022

Newly-diagnosed Glioblastoma Trial in Beijing (CAN008, Placebo)

Recruiting
  • Newly-diagnosed Glioblastoma
  • Beijing, Beijing, China
    Beijing Tiantan Hospital, Capital Medical University
Jul 10, 2022

Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant Trial in New York (Repeated Superselective Intraarterial Cerebral

Recruiting
  • Glioblastoma
  • +6 more
  • Repeated Superselective Intraarterial Cerebral infusion (SIACI) of Bevacizumab (Avastin) with Temozolomide and Radiation
  • Temozolomide and Radiation Alone
  • New York, New York
    Lenox Hill Brain Tumor Center
May 5, 2022

Glioblastoma Multiforme, Brain Tumor Trial in New York (Bevacizumab)

Active, not recruiting
  • Glioblastoma Multiforme
  • Brain Tumor
  • New York, New York
    Lenox Hill Brain Tumor Center
Jun 20, 2022

Newly Diagnosed Glioblastoma Multiforme Trial (SI-053)

Not yet recruiting
  • Newly Diagnosed Glioblastoma Multiforme
  • (no location specified)
Apr 4, 2022

Standard Radiotherapy and TMZ Patients With GBM

Not yet recruiting
  • Glioblastoma
  • Glioma, Malignant
    • Durham, North Carolina
      The Preston Robert Tisch Brain Tumor Center at Duke University
    Jan 20, 2023

    Newly Diagnosed Glioblastoma Trial (Pembrolizumab)

    Not yet recruiting
    • Newly Diagnosed Glioblastoma
    • (no location specified)
    Feb 22, 2022

    Newly Diagnosed Glioblastoma Trial in United States (AV-GBM-1)

    Active, not recruiting
    • Newly Diagnosed Glioblastoma
    • AV-GBM-1
    • La Jolla, California
    • +7 more
    Dec 14, 2021